SAT-162 Hepatocyte Nuclear Factor-4α (HNF44α) as a Target to Treat DM
Gustavo Jorge dos Santos(Universidade de São Paulo), Antônio C. Boschero(Universidade Estadual de Campinas (UNICAMP)), Carolina Ruoso(Polydoro Ernani de São Thiago University Hospital), Alex Rafacho(Universidade Federal de Santa Catarina), Sèverine Pechberty(Délégation Paris 5), Sandra Mara Ferreira(Universidade Estadual de Campinas (UNICAMP)), Fernanda Ortis(Universidade de São Paulo), Angelo Di Stefano
Cited by 0
Related Papers
The Human Pancreatic Islet Transcriptome: Expression of Candidate Genes for Type 1 Diabetes and the Impact of Pro-Inflammatory Cytokines
|PLoS Genetics|2012|478
Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes
|Journal of Endocrinology|2014|214
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans
|Journal of Endocrinology|2011|119
Participation of prolactin receptors and phosphatidylinositol 3-kinase and MAP kinase pathways in the increase in pancreatic islet mass and sensitivity to glucose during pregnancy
|Journal of Endocrinology|2004|111
High doses of dexamethasone induce increased β-cell proliferation in pancreatic rat islets
|American Journal of Physiology-Endocrinology and Metabolism|2009|106